Home » News and Development » GW Pharmaceuticals in advanced epilepsy trials for CBD rich cannabis concentrate

GW Pharmaceuticals in advanced epilepsy trials for CBD rich cannabis concentrate



Above, cannabis oil produced from CBD-rich cannabis
GW Pharmaceuticals, with their Sativex product have one of the few internationally legal cannabis concentrates available.  Sativex is a 1:1 THC:CBD oral spray which is used mainly for treatment of MS related symptoms.  Their next product is another cannabis extract and is called Epidiolex, its a CBD-dominant concentrate used for treatment of drug resistant epilepsy.  The cannabis community already know that CBD can be used to stop epileptic fits, but the formal Stage 3 ‘double blind’ clinical trials will be welcomed by many people keen to see just how effective cannabis is in dealing with epilepsy.  Children with Dravets syndrome in the USA are already using cannabis oil in Colorado (extracted from the CDB-dominant Charlottes Web variety).  In the new trials people with Lennox-Gastaut syndrome will be assessed with the CBD-rich Epidiolex.
More information on this story is here https://uk.advfn.com/news/UKREG/2015/article/66800238
June 2nd 2015

Related items

Recent comments (0)

Leave a comment

Your comment
Type the characters you see in the picture below
I would like to receive the newsletter
Contact   |   Disclaimer   |   Privacy policy, terms and conditions

Dutch Passion advise their customers to reassure themselves of local applicable laws and regulations before germination. Dutch Passion cannot be held responsible for the actions of those who act against laws and regulations that apply in their locality. Cannabis seeds should be kept as collectible souvenirs by anyone in an area where cultivation of cannabis is not legal.